If we’re worried about plagiarism why not train students to work with AI writing assistants and learn to think through the dialogue? We could teach them to use chatbots to get ideas, to generate alternative approaches to a topic, to research questions, and to edit what they get into a coherent whole.
At the same time, we also have to teach our students to be careful and think critically about engaging with AIs and assessing the credibility of what they say.
By thinking through dialogue we could all rediscover the rich history and potential of this form of engagement.
Scientists at University of California San Diego School of Medicine have developed an artificial intelligence (AI)-based strategy for discovering high-affinity antibody drugs.
In the study, published January 28, 2023 in Nature Communications, researchers used the approach to identify a new antibody that binds a major cancer target 17-fold tighter than an existing antibody drug. The authors say the pipeline could accelerate the discovery of novel drugs against cancer and other diseases such as COVID-19 and rheumatoid arthritis.
In order to be a successful drug, an antibody has to bind tightly to its target. To find such antibodies, researchers typically start with a known antibody amino acid sequence and use bacterial or yeast cells to produce a series of new antibodies with variations of that sequence. These mutants are then evaluated for their ability to bind the target antigen. The subset of antibodies that work best are then subjected to another round of mutations and evaluations, and this cycle repeats until a set of tightly-binding finalists emerges.
The phone, tablet or laptop you’re reading this on is likely having its battery slowly drained because of a surprising and widespread manufacturing flaw, according to researchers in Halifax.
“This is something that is totally unexpected and something that probably no one thought of,” said Michael Metzger, an assistant professor at Dalhousie University.
The problem? Tiny pieces of tape that hold the battery components together are made from the wrong type of plastic.
But every once in a while, an idea is so powerful and so profound its effects are felt much faster.
That’s been the case with CRISPR gene editing, which celebrates a 10th anniversary this month. It has already had a substantial impact on laboratory science, improving precision and speeding research, and it has led to clinical trials for a handful of rare diseases and cancers.
Over the next decade, scientists predict, CRISPR will yield multiple approved medical treatments and be used to modify crops, making them more productive and resistant to disease and climate change.
God, they say, is in the details. But could God also be in our frontal lobes? Every culture from the dawn of humankind has imagined planes of existence beyond the reach of our senses, spiritual domains that shape our Earthly experiences. Why do beliefs of the fantastic hold such powerful sway over our species? Is there something in our evolutionary history that points to an answer? Does neuroscience hold the key? Straddling the gap between science and religion, Brian Greene is joined by renowned neuroscientists, anthropologists, and evolutionary biologists, to explore one of the most profound mysteries of our existence.
PARTICIPANTS: Lisa Barrett, Barbara J. King, Zoran Josipovic, Steven Pinker.
00:00 Intro. 03:05 Demis Hassabis: Founder of DeepMind. 14:30 DeepMind: Mission and early years. 19:18 Beating the Atari games. 27:22 Elon Musk: thoughts on DeepMind. 28:42 Elon Musk: AI could destroy humanity. 30:20 AlphaGo. 36:14 AlphaZero. 38:30 MuZero. 40:56 WaveNet. 43:18 AlphaStar. 45:33 AlphaFold. 48:39 Gato, A generalist agent. 50:02 Solving *everything else*
This premium episode is a documentary-style video about the history and importance of Alphabet subsidiary, DeepMind. Demis Hassabis, founder, was a chess prodigy by the time he was 13 years old. He went on to conclude he wanted to “solve intelligence” by building artificial intelligence agents and using digital tools. The team at DeepMind has created systems that defeated the world’s best chess and Go professionals. They’ve also cracked the code on the infamous ‘protein-folding problem.’ Demis Hassabis and DeepMind are fascinating. Moreover, they’re still just getting started.
Neura Pod is a series covering topics related to Neuralink, Inc. Topics such as brain-machine interfaces, brain injuries, and artificial intelligence will be explored. Host Ryan Tanaka synthesizes informationopinions, and conducts interviews to easily learn about Neuralink and its future.
